| ASA I |
A normal healthy patient |
Healthy, non-smoking, no or minimal alcohol use |
Healthy (no acute or chronic disease), normal BMI percentile for age |
- |
| ASA II |
A patient with mild systemic disease |
Mild diseases only without
substantive functional limitations.
Current smoker, social alcohol
drinker, pregnancy, obesity
(30<BMI<40), well-controlled
DM/HTN, mild lung disease
|
Asymptomatic congenital cardiac disease, well
controlled dysrhythmias, asthma without exacerbation,
well controlled epilepsy, non-insulin dependent
diabetes mellitus, abnormal BMI percentile for age,
mild/moderate OSA, oncologic state in remission,
autism with mild limitations
|
Normal pregnancy*, well
controlled gestational HTN,
controlled preeclampsia without
severe features, diet-controlled
gestational DM.
|
| ASA III |
A patient with severe systemic disease
|
Substantive functional limitations;
One or more moderate to severe
diseases. Poorly controlled DM or
HTN, COPD, morbid obesity (BMI
≥40), active hepatitis, alcohol
dependence or abuse, implanted
pacemaker, moderate reduction of
ejection fraction, ESRD undergoing
regularly scheduled dialysis, history
(>3 months) of MI, CVA, TIA, or
CAD/stents
|
Uncorrected stable congenital cardiac abnormality,
asthma with exacerbation, poorly controlled epilepsy,
insulin dependent diabetes mellitus, morbid obesity,
malnutrition, severe OSA, oncologic state, renal
failure, muscular dystrophy, cystic fibrosis, history of
organ transplantation, brain/spinal cord malformation,
symptomatic hydrocephalus, premature infant PCA
<60 weeks, autism with severe limitations, metabolic
disease, difficult airway, long term parenteral nutrition.
Full term infants <6 weeks of age.
|
Preeclampsia with severe
features, gestational DM with
complications or high insulin
requirements, a thrombophilic
disease requiring
anticoagulation.
|
| ASA IV |
A patient with
severe systemic
disease that is a
constant threat to
life
|
Recent (<3 months) MI, CVA, TIA
or CAD/stents, ongoing cardiac
ischemia or severe valve
dysfunction, severe reduction of
ejection fraction, shock, sepsis,
DIC, ARD or ESRD not undergoing
regularly scheduled dialysis
|
Symptomatic congenital cardiac abnormality,
congestive heart failure, active sequelae of
prematurity, acute hypoxic-ischemic encephalopathy,
shock, sepsis, disseminated intravascular coagulation,
automatic implantable cardioverter-defibrillator,
ventilator dependence, endocrinopathy, severe trauma,
severe respiratory distress, advanced oncologic state.
|
Preeclampsia with severe
features complicated by HELLP
or other adverse event,
peripartum cardiomyopathy
with EF <40,
uncorrected/decompensated
heart disease, acquired or
congenital.
|
| ASA V |
A moribund patient
who is not
expected to survive
without the
operation
|
Ruptured abdominal/thoracic
aneurysm, massive trauma,
intracranial bleed with mass effect,
ischemic bowel in the face of
significant cardiac pathology or
multiple organ/system dysfunction
|
Massive trauma, intracranial hemorrhage with mass effect, patient requiring
ECMO, respiratory failure or arrest, malignant hypertension, decompensated
congestive heart failure, hepatic encephalopathy, ischemic bowel or multiple
organ/system dysfunction.
|
Uterine rupture |
| ASA VI |
A declared brain-dead patient whose
organs are being
removed for donor
purposes
|
|